XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements and Investments
6 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Investments
Note 6—Fair Value Measurements and Investments
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 Fair Value Measurements
Using Inputs Considered as
 Level 1Level 2
 March 31,
2024
September 30,
2023
March 31,
2024
September 30,
2023
 (in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds
$9,050 $13,504 $ $— 
U.S. Treasury securities
834 301  — 
Investment securities:
Marketable equity securities
374 339  — 
U.S. government-sponsored debt securities
 — 1,510 1,108 
U.S. Treasury securities
5,918 4,316  — 
Other current and non-current assets:
Money market funds
29 23  — 
Derivative instruments
 — 210 293 
Total $16,205 $18,483 $1,720 $1,401 
Liabilities
Accrued compensation and benefits:
Deferred compensation liability
$223 $175 $ $— 
Accrued and other liabilities:
Derivative instruments
 — 278 396 
Total $223 $175 $278 $396 
Level 1 assets and liabilities. Money market funds, U.S. Treasury securities and marketable equity securities are classified as Level 1 within the fair value hierarchy, as fair value is based on unadjusted quoted prices in active markets for identical assets. The Company’s deferred compensation liability is measured at fair value based on marketable equity securities held under the deferred compensation plan.
Level 2 assets and liabilities. The fair value of U.S. government-sponsored debt securities, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. Derivative instruments are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data.
U.S. Government-sponsored Debt Securities and U.S. Treasury Securities
The amortized cost, unrealized gains and losses and fair value of debt securities were as follows:
March 31, 2024
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$1,511 $— $(1)$1,510 
U.S. Treasury securities6,782 (34)6,752 
Total$8,293 $4 $(35)$8,262 
September 30, 2023
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$1,109 $$(2)$1,108 
U.S. Treasury securities4,697 — (80)4,617 
Total$5,806 $$(82)$5,725 
Debt securities with unrealized losses for less than 12 months and 12 months or greater were as follows:
March 31, 2024
Less Than 12 Months
12 Months or Greater
Fair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
(in millions)
U.S. government-sponsored debt securities$1,282 $(1)$— $— 
U.S. Treasury securities2,789 (6)1,870 (28)
Total$4,071 $(7)$1,870 $(28)
September 30, 2023
Less Than 12 Months
12 Months or Greater
Fair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
(in millions)
U.S. government-sponsored debt securities$412 $(2)$50 $— 
U.S. Treasury securities1,360 (12)2,128 (68)
Total$1,772 $(14)$2,178 $(68)
The unrealized losses were primarily attributable to changes in interest rates.
The stated maturities of debt securities were as follows:
March 31,
2024
 (in millions)
Due within one year$5,170 
Due after one year through five years
3,092 
Total$8,262 
Equity Securities
For the three months ended March 31, 2024 and 2023, the Company recognized net unrealized losses of $23 million and $82 million, respectively, on marketable and non-marketable equity securities held as of period end. For the six months ended March 31, 2024 and 2023, the Company recognized net unrealized gains of $13 million and net unrealized losses of $184 million, respectively, on marketable and non-marketable equity securities held as of period end.
Fair value measurement alternative. The Company’s investments in privately held companies do not have readily determinable fair values. These investments are measured at fair value on a non-recurring basis and are classified as Level 3 due to the absence of quoted market prices, the inherent lack of liquidity and the fact that significant inputs used to measure fair value are unobservable and require management’s judgment.
The following table summarizes the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative:
March 31,
2024
(in millions)
Initial cost basis
$710 
Adjustments:
Upward adjustments
909 
Downward adjustments (including impairment)
(445)
Carrying amount
$1,174 
Unrealized gains and losses of the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative were as follows:
Three Months Ended
March 31,
Six Months Ended
March 31,
2024202320242023
(in millions)
Upward adjustments$ $$9 $19 
Downward adjustments (including impairment)$(15)$(89)$(15)$(89)
Other Fair Value Disclosures
Debt. Debt instruments are measured at amortized cost on the Company’s consolidated balance sheets. The fair value of the debt instruments, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. If measured at fair value in the financial statements, these instruments would be classified as Level 2 in the fair value hierarchy. As of March 31, 2024, the carrying value and estimated fair value of debt was $20.6 billion and $18.6 billion, respectively. As of September 30, 2023, the carrying value and estimated fair value of debt was $20.5 billion and $17.7 billion, respectively.
Other financial instruments not measured at fair value. As of March 31, 2024, the carrying values of settlement receivable and payable and customer collateral are an approximate fair value due to their generally short maturities. If measured at fair value in the financial statements, these financial instruments would be classified as Level 2 in the fair value hierarchy.
Non-financial assets. Certain non-financial assets such as goodwill, intangible assets and property, equipment and technology are subject to non-recurring fair value measurements if they are deemed to be impaired. The Company performed an annual impairment review of its indefinite-lived intangible assets and goodwill as of February 1, 2024, and concluded there was no impairment as of that date. No recent events or changes in circumstances indicated that impairment existed as of March 31, 2024